Journal of Inflammation Research
Volume 15, 2022 - Issue
Open access
65
Views
1
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH
The Effect of PD-1 Inhibitor Combined with Irradiation on HMGB1-Associated Inflammatory Cytokines and Myocardial Injury
Jie Bai1 Department of Oncology, The Affiliated Hospital of Guizhou Medical University, Guiyang, People’s Republic of China;2 Department of Oncology, The Affiliated Cancer Hospital of Guizhou Medical University, Guiyang, People’s Republic of China;3 Department of Oncology, School of Clinical Medicine, Guizhou Medical University, Guiyang, People’s Republic of Chinahttps://orcid.org/0000-0002-4325-812X
, Bibo Wu1 Department of Oncology, The Affiliated Hospital of Guizhou Medical University, Guiyang, People’s Republic of China;2 Department of Oncology, The Affiliated Cancer Hospital of Guizhou Medical University, Guiyang, People’s Republic of China;3 Department of Oncology, School of Clinical Medicine, Guizhou Medical University, Guiyang, People’s Republic of China
, Shasha Zhao1 Department of Oncology, The Affiliated Hospital of Guizhou Medical University, Guiyang, People’s Republic of China;2 Department of Oncology, The Affiliated Cancer Hospital of Guizhou Medical University, Guiyang, People’s Republic of China;3 Department of Oncology, School of Clinical Medicine, Guizhou Medical University, Guiyang, People’s Republic of China
, Gang Wang1 Department of Oncology, The Affiliated Hospital of Guizhou Medical University, Guiyang, People’s Republic of China;2 Department of Oncology, The Affiliated Cancer Hospital of Guizhou Medical University, Guiyang, People’s Republic of China;3 Department of Oncology, School of Clinical Medicine, Guizhou Medical University, Guiyang, People’s Republic of China
, Shengfa Su1 Department of Oncology, The Affiliated Hospital of Guizhou Medical University, Guiyang, People’s Republic of China;2 Department of Oncology, The Affiliated Cancer Hospital of Guizhou Medical University, Guiyang, People’s Republic of China;3 Department of Oncology, School of Clinical Medicine, Guizhou Medical University, Guiyang, People’s Republic of ChinaCorrespondence[email protected]
, Bing Lu1 Department of Oncology, The Affiliated Hospital of Guizhou Medical University, Guiyang, People’s Republic of China;2 Department of Oncology, The Affiliated Cancer Hospital of Guizhou Medical University, Guiyang, People’s Republic of China;3 Department of Oncology, School of Clinical Medicine, Guizhou Medical University, Guiyang, People’s Republic of China
, Yinxiang Hu1 Department of Oncology, The Affiliated Hospital of Guizhou Medical University, Guiyang, People’s Republic of China;2 Department of Oncology, The Affiliated Cancer Hospital of Guizhou Medical University, Guiyang, People’s Republic of China;3 Department of Oncology, School of Clinical Medicine, Guizhou Medical University, Guiyang, People’s Republic of China
, Yichao Geng1 Department of Oncology, The Affiliated Hospital of Guizhou Medical University, Guiyang, People’s Republic of China;3 Department of Oncology, School of Clinical Medicine, Guizhou Medical University, Guiyang, People’s Republic of Chinahttps://orcid.org/0000-0001-5157-4571
, Zhengneng Guo1 Department of Oncology, The Affiliated Hospital of Guizhou Medical University, Guiyang, People’s Republic of China;2 Department of Oncology, The Affiliated Cancer Hospital of Guizhou Medical University, Guiyang, People’s Republic of China;3 Department of Oncology, School of Clinical Medicine, Guizhou Medical University, Guiyang, People’s Republic of China
, Jun Wan2 Department of Oncology, The Affiliated Cancer Hospital of Guizhou Medical University, Guiyang, People’s Republic of China;3 Department of Oncology, School of Clinical Medicine, Guizhou Medical University, Guiyang, People’s Republic of China
, Weiwei OuYang1 Department of Oncology, The Affiliated Hospital of Guizhou Medical University, Guiyang, People’s Republic of China;2 Department of Oncology, The Affiliated Cancer Hospital of Guizhou Medical University, Guiyang, People’s Republic of China;3 Department of Oncology, School of Clinical Medicine, Guizhou Medical University, Guiyang, People’s Republic of China
, Cheng Hu1 Department of Oncology, The Affiliated Hospital of Guizhou Medical University, Guiyang, People’s Republic of China;2 Department of Oncology, The Affiliated Cancer Hospital of Guizhou Medical University, Guiyang, People’s Republic of China;3 Department of Oncology, School of Clinical Medicine, Guizhou Medical University, Guiyang, People’s Republic of China
& Jie Liu1 Department of Oncology, The Affiliated Hospital of Guizhou Medical University, Guiyang, People’s Republic of China;2 Department of Oncology, The Affiliated Cancer Hospital of Guizhou Medical University, Guiyang, People’s Republic of China;3 Department of Oncology, School of Clinical Medicine, Guizhou Medical University, Guiyang, People’s Republic of China
show all
Pages 6357-6371
|
Received 01 Sep 2022, Accepted 08 Nov 2022, Published online: 18 Nov 2022
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.